Markéta Bednaříková

department of internal medicine, hematology and oncology, university hospital brno and faculty of medicine, masaryk university, brno, czech republic

H指数:12

被引数:1,267

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prognostic Impact of PD-L1 Expression in Ovarian Cancer: Analysis of a Real-World Cohort Treated With Primary Platinum-Based Chemotherapy

PD-L1表达在卵巢癌中的预后影响：接受一线铂类化疗的真实世界队列分析

Cancer Medicine

IF3.1

2026-09-140

OAAI

SMARCA4-deficient dedifferentiated ovarian carcinoma with rapid progression during adjuvant platinum-based chemotherapy: a case report and implications for molecular-driven treatment strategies

SMARCA4缺陷型去分化卵巢癌在辅助铂类化疗期间快速进展：一例病例报告及其对分子驱动治疗策略的启示

Therapeutic Advances in Medical Oncology

IF4.2

2025-10-180

Cytological and Immunocytochemistry Findings in Fallopian Tube Brush Specimens and Their Correlation With Histology

输卵管刷检标本的细胞学及免疫细胞化学发现及其与组织学的关系

CYTOPATHOLOGY

IF1.1

2025-09-010

PRE

Real-World Data From a Molecular Tumor Board-Assisted Cancer Care From a Single Center in The Czech Republic: Is Precision Oncology an Accessible Option, or a Privilege for a Minority of Patients?

来自捷克共和国单中心的分子肿瘤委员会辅助癌症治疗的真实世界数据：精准肿瘤学是一种可及的选择，还是少数患者的一种特权？

Cancer Medicine

IF3.1

2025-08-040

OAAI

Improving pre-operative binary grading: relevance of p53 and PR expression in grade 2 endometrioid endometrial carcinoma

改善术前二元分级：p53和PR表达在2级子宫内膜样子宫内膜癌中的相关性

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

IF4.7

2025-02-010

OAAI

Meijs-Hermanns, Puk; Werner, Henrica M. J.; Kooreman, Loes; Bretova, Petra; Weinberger, Vit; Vrede, Stephanie; Alcala, Luthy S. M.; Amant, Frederic; Asberger, Jasmin; Bednarikova, Marketa; Boll, Dorry; Bronkhorst, Carolien M.; Bulten, Johan; Gil-Moreno, Antonio; Haldorsen, Ingfrid S.; Hausnerova, Jitka; Huvila, Jutta; Koskas, Martin; Krakstad, Camilla; Kuesters-Vandevelde, Heidi; Moreno, Gemma Mancebo; Matias-Guiu, Xavier; Ngo, Huy; Pijlman, Brenda M.; Santacana, Maria; Smink, Marieke; Troviko, Jone; Verhoef, Viola M. J.; van de Vijver, Koen; van Hamont, Dennis; van der Wurff, Anneke A. M.; Pijnenborg, Johanna M. A.; Visser, Nicole C. M.

Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed high-risk, locally advanced cervical cancer (ENGOT-cx11/ GOG-3047/KEYNOTE-A18): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 trial

Pembrolizumab或安慰剂联合放化疗，然后用pembrolizumab或安慰剂治疗新诊断的高危局部晚期宫颈癌 (ENGOT-cx11/ GOG-3047/KEYNOTE-A18): 一项随机，双盲，安慰剂对照的3期试验的总生存期结果

LANCET

IF88.5

2024-10-016

PRE

Lorusso, Domenica; Xiang, Yang; Hasegawa, Kosei; Scambia, Giovanni; Leiva, Manuel; Ramos-Elias, Pier; Acevedo, Alejandro; Cvek, Jakub; Randall, Leslie; Gomes, Andrea Juliana Pereira de Santana; Mejia, Fernando Contreras; Helpman, Limor; Akilli, Huseyin; Lee, Jung-Yun; Saevets, Valeriya; Zagouri, Flora; Gilbert, Lucy; Sehouli, Jalid; Tharavichitkul, Ekkasit; Lindemann, Kristina; Colombo, Nicoletta; Chang, Chih-Long; Bednarikova, Marketa; Zhu, Hong; Oaknin, Ana; Christiaens, Melissa; Petru, Edgar; Usami, Tomoka; Liu, Peng; Yamada, Karin; Toker, Sarper; Keefe, Stephen M.; Pignata, Sandro; Duska, Linda R.

Proteomic analysis of ascitic extracellular vesicles describes tumour microenvironment and predicts patient survival in ovarian cancer

JOURNAL OF EXTRACELLULAR VESICLES

IF14.5

2024-03-154